Abstract
The aim of this registry-based retrospective study was to analyze the outcome of second allogeneic hematopoietic SCT (alloHSCT_2) performed in patients with lymphoma who had relapsed after a first allogeneic transplant (alloHSCT_1). Patients ⩾18 years who had received an alloHSCT_2 for lymphoma relapse between 2000 and 2011 were eligible. One hundred and forty patients were identified. The diagnosis was Hodgkin lymphoma (HL) in 31%, diffuse large B-cell lymphoma in 14%, T-cell lymphoma in 12%, indolent lymphoma in 19%, mantle cell lymphoma in 16% and other lymphomas in 8% of the patients. The median interval from alloHSCT_1 to alloHSCT_2 was 19 (range 4-116) months. Disease status at alloHSCT_2 was chemosensitive in 46%, refractory in 43% and unknown in 11% of the patients. Three-year PFS, OS, relapse incidence and nonrelapse mortality were 19%, 29%, 58% and 23%, respectively. PFS and OS were significantly affected by refractory disease at alloHSCT_2 and a short interval between alloHSCT_1 and alloHSCT_2. Long-term PFS was observed across all lymphoma subsets except for aggressive B-cell lymphoma. In conclusion, alloHSCT_2 is feasible and can result in long-term disease control in patients with lymphoma recurrence after alloHSC...Continue Reading
References
Feb 26, 2000·British Journal of Haematology·M MichalletN Feguex
Aug 24, 2004·Bone Marrow Transplantation·M EapenM deLima
Nov 2, 2004·Bone Marrow Transplantation·A GratwohlUNKNOWN Accreditation Committee of the European Group for Blood and Marrow Transplantation
Jun 28, 2007·Blood·Christoph KahlRainer Storb
Dec 19, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anna SuredaNorbert Schmitz
Apr 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven Le GouillUNKNOWN Société Française de Greffe de Moëlle et de Thérapie Cellulaire
Aug 30, 2008·Bone Marrow Transplantation·B E ShawN H Russell
Jan 27, 2009·Blood·Constantine S TamIssa F Khouri
Apr 14, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Koen van BesienParameswaran N Hari
Nov 10, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Andrea BacigalupoMary Horowitz
Jul 8, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kirsty J ThomsonStephen Mackinnon
Feb 16, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roel J W van KampenAnna Sureda
Feb 23, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Kitsada WudhikarnDaniel J Weisdorf
May 4, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Ron RamAjay K Gopal
Sep 10, 2011·Leukemia·A DoderoP Corradini
Oct 14, 2011·Haematologica·Anna SuredaNorbert Schmitz
Feb 5, 2013·Bone Marrow Transplantation·P ChristopoulosJ Finke
Jun 19, 2013·Bone Marrow Transplantation·S P RobinsonA Sureda
Jul 31, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sonali M SmithParameswaran N Hari
Aug 7, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maximilian ChristopeitChristoph Schmid
Dec 18, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Timothy S FenskeParameswaran N Hari
Dec 24, 2013·Bone Marrow Transplantation·M KoenigsmannD Niederwieser
Feb 11, 2014·Bone Marrow Transplantation·I AviviUNKNOWN EBMT Lymphoma Working Party
Mar 4, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S DietrichP Dreger
Mar 19, 2014·Bone Marrow Transplantation·J R PasswegUNKNOWN European Society for Blood and Marrow Transplantation EBMT
May 16, 2014·The Lancet Oncology·Bertram GlassUNKNOWN German High-Grade Lymphoma Study Group
Citations
Dec 15, 2015·Expert Opinion on Biological Therapy·Massimo MartinoB Bruno
Jan 21, 2016·Journal of Immunology Research·Roberta FedeleFortunato Morabito
Mar 16, 2016·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Hasan Sami Göksoy, Mutlu Arat
May 24, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Nicoletta CieriJacopo Peccatori
Jan 23, 2019·Leukemia & Lymphoma·Boglarka GyurkoczaBrenda M Sandmaier
May 26, 2018·Bone Marrow Transplantation·Anna SuredaDavid L Porter
Aug 22, 2018·Chinese Medical Journal·Wen-Rong Huang, Dai-Hong Liu
Dec 14, 2018·Bone Marrow Transplantation·Guillermo OrtíDavid Valcárcel
Jan 21, 2021·Cancers·Miriam MarangonMarco Ladetto
Jan 10, 2020·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Peter DregerUNKNOWN European Society for Blood and Marrow Transplantation (EBMT) and the Center for International Blood and Marrow Transplant Re
Jul 1, 2020·Hematology/oncology and Stem Cell Therapy·Madiha Iqbal, Mohamed A Kharfan-Dabaja
Jul 20, 2021·Frontiers of Medicine·Tingting HanXiaohui Zhang